Free Trial

Pliant Therapeutics (PLRX) SEC Filings & 10K Form

Pliant Therapeutics logo
$1.33 -0.04 (-2.92%)
Closing price 04:00 PM Eastern
Extended Trading
$1.34 +0.01 (+0.75%)
As of 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Pliant Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
3:39 PM
Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
9:45 AM
Pliant Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SCHEDULE 13G/A
05/01/2025
3:13 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:17 PM
Pliant Therapeutics (Filer)
Form DEF 14A
04/23/2025
3:19 PM
Pliant Therapeutics (Filer)
Form DEFA14A
04/10/2025
3:30 PM
Pliant Therapeutics (Filer)
Form PRE 14A
03/13/2025
7:49 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
7:05 AM
Pliant Therapeutics (Filer)
Form 8-A12B
03/10/2025
4:24 PM
Pliant Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D
03/07/2025
9:01 AM
FMR LLC (Filed by)
Pliant Therapeutics (Subject)
Form SCHEDULE 13G/A
03/03/2025
3:18 PM
Pliant Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
7:01 PM
Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
8:00 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
6:01 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
5:14 PM
Cheung Lily (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:01 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:04 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:07 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:10 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:58 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
4:55 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
4:58 PM
Cheung Lily (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:00 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:02 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:05 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:07 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:23 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
8:00 PM
Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G
11/12/2024
10:53 AM
Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G/A
10/04/2024
4:34 PM
Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
09/27/2024
3:11 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:13 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
10:54 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
5:37 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:41 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:45 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:15 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:22 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:01 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:47 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:54 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
07/11/2024
3:41 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Cline Darren S (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:57 PM
Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:52 PM
Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PLRX) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners